Sun Pharma moves up on inking pact to acquire 60% stake in Vivaldis Health and Foods
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Sun Pharmaceutical Industries is currently trading at Rs. 979.95, up by 7.15 points or 0.73% from its previous closing of Rs. 972.80 on the BSE.
The scrip opened at Rs. 980.05 and has touched a high and low of Rs. 981.00 and Rs. 963.95 respectively. So far 24819 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1071.90 on 30-Jan-2023 and a 52 week low of Rs. 789.75 on 17-Jun-2022.
Last one week high and low of the scrip stood at Rs. 982.85 and Rs. 947.25 respectively. The current market cap of the company is Rs. 233407.31 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.01% and 9.51% respectively.
Sun Pharmaceutical Industries has entered into an agreement to acquire 60% shareholding in Vivaldis Health and Foods from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions. Cost of acquisition is Rs 143.30 crore subject to customary closing adjustments for 60% shareholding. The said acquisition is expected to be completed by the end of May 2023.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
